Rufinamide Patent Expiration
Rufinamide is Used for managing and treating epilepsy. It was first introduced by Eisai Inc
Rufinamide Patents
Given below is the list of patents protecting Rufinamide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Banzel |
US6740669 (Pediatric) | Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic |
May 14, 2023
(Expired) | Eisai Inc |
| Banzel | US6740669 | Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic |
Nov 14, 2022
(Expired) | Eisai Inc |
| Banzel |
US7750028 (Pediatric) | Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1, 2,3-triazole-4-carboxamide |
Apr 19, 2019
(Expired) | Eisai Inc |
| Banzel |
US8076362 (Pediatric) | Crystal modification A of 1-(2,6-difluorobenzyI)-1 H-1,2,3-triazole-4-carboxamide and dosage forms and formulations thereof |
Dec 08, 2018
(Expired) | Eisai Inc |
| Banzel | US7750028 | Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1, 2,3-triazole-4-carboxamide |
Oct 19, 2018
(Expired) | Eisai Inc |
| Banzel | US8076362 | Crystal modification A of 1-(2,6-difluorobenzyI)-1 H-1,2,3-triazole-4-carboxamide and dosage forms and formulations thereof |
Jun 08, 2018
(Expired) | Eisai Inc |
Rufinamide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List